These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. Martínez V; Rivier J; Coy D; Taché Y J Pharmacol Exp Ther; 2000 Jun; 293(3):1099-105. PubMed ID: 10869415 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat. Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin inhibition of acid and histamine release by activation of somatostatin receptor subtype 2 receptors in rats. Aurang K; Wang J; Lloyd KC J Pharmacol Exp Ther; 1997 Apr; 281(1):245-52. PubMed ID: 9103503 [TBL] [Abstract][Full Text] [Related]
5. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. Spary EJ; Maqbool A; Batten TF J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081 [TBL] [Abstract][Full Text] [Related]
6. The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. Piwko C; Thoss VS; Probst A; Hoyer D J Recept Signal Transduct Res; 1997; 17(1-3):385-405. PubMed ID: 9029503 [TBL] [Abstract][Full Text] [Related]
7. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro. Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235 [TBL] [Abstract][Full Text] [Related]
8. Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Lloyd KC; Wang J; Aurang K; Grönhed P; Coy DH; Walsh JH Am J Physiol; 1995 Jan; 268(1 Pt 1):G102-6. PubMed ID: 7840190 [TBL] [Abstract][Full Text] [Related]
9. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures. Siehler S; Nunn C; Zupanc GK; Hoyer D Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149 [TBL] [Abstract][Full Text] [Related]
10. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. Masmoudi O; Gandolfo P; Tokay T; Leprince J; Ravni A; Vaudry H; Tonon MC J Neurochem; 2005 Aug; 94(3):561-71. PubMed ID: 16033415 [TBL] [Abstract][Full Text] [Related]
11. Influence of intracisternal injection of somatostatin analog receptor subtypes 2, 3 and 5 on gastric acid secretion in conscious rats. Martínez V; Coy DH; Taché Y Neurosci Lett; 1995 Feb; 186(2-3):79-82. PubMed ID: 7777203 [TBL] [Abstract][Full Text] [Related]
12. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation. Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells. Lauder H; Sellers LA; Fan TP; Feniuk W; Humphrey PP Br J Pharmacol; 1997 Oct; 122(4):663-70. PubMed ID: 9375962 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin inhibits gastrin release and acid secretion by activating sst2 in dogs. Lloyd KC; Amirmoazzami S; Friedik F; Chew P; Walsh JH Am J Physiol; 1997 Jun; 272(6 Pt 1):G1481-8. PubMed ID: 9227485 [TBL] [Abstract][Full Text] [Related]
15. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620 [TBL] [Abstract][Full Text] [Related]
16. Drug design at peptide receptors: somatostatin receptor ligands. Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345 [TBL] [Abstract][Full Text] [Related]
17. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion. Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371 [TBL] [Abstract][Full Text] [Related]
18. Microinjection of exogenous somatostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in rats. Liao Z; Li ZS; Lu Y; Wang WZ Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G746-52. PubMed ID: 17138968 [TBL] [Abstract][Full Text] [Related]
19. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects. Park S; Kamegai J; Kineman RD Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Zaki M; Harrington L; McCuen R; Coy DH; Arimura A; Schubert ML Gastroenterology; 1996 Oct; 111(4):919-24. PubMed ID: 8831586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]